Aker BioMarine has recruited Maja Bævre-Jensen and Karen Kirstine Østerhus for its QRILL Aqua Norway-based team. So, they will work closely with the fish farming industry to find tailor-made solutions for each customer.
Therefore, Maja Bævre-Jensen will take the role of Business Development Director. On the other hand, Karen Kirstine Østerhus is appointed as Business Development Manager.
Meanwhile, Sigve Nordrum, EVP Animal Health & Nutrition in Aker BioMarine explained the company's plans: "We are only at the beginning of uncovering the full potential of QRILL Aqua for salmon in Norway. Our competent people are key in helping our customers and stakeholders learn more about the health benefits of Antarctic krill."
"Maja and Karen both possess solid aquaculture industry knowledge and a passion for exploring new and future-looking solutions for the Norwegian Industry. Strengthening this team is an important part of our increasing involvement with the Aqua Industry in Norway," he added.
Firstly, Maja Bævre-Jensen has worked for the past five years with the Norwegian Seafood Research Fund. She has 20 years of aquaculture experience. She holds a master's degree in Aqua Medicine from the Norwegian Arctic University, with a specialization in sea lice.
Regarding her appointment, she said: "I see Aker BioMarine as a place where everyone is encouraged to bring new ideas to life. I'm a strong believer in the power and potential of QRILL Aqua as an ingredient. I'm excited to explore and develop new business opportunities to help fish farmers reach their goals, alongside this talented team."
Secondly, Karen Kirstine Østerhus has been focusing on fish ready to be harvested and collaborated with farmers throughout Norway. Before, she worked at STIM, dealing with bacteriophages, feed, and other fish health-related products. Also, she holds a bachelor's degree in Aquaculture Management from Nord University.
"I'm excited about the possibility to contribute to improving fish health and the sustainability of the industry. With a lot of passion for the industry and as a self-proclaimed fish nerd, the opportunity of becoming a part of Aker BioMarine as such an innovative and forward-looking company is a dream come true," Østerhus stated.
QRILL Aqua's key market differentiator is that it improves fish health and performance. In aqua diets, QRILL™ Aqua functions as a feeding stimulant leading to increased feed uptake and enhanced growth. QRILL™ Aqua improves growth performance, health, fillet quality, and stress and disease resistance of fish.
Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Listed on Oslo Stock Exchange, the company develops krill-based ingredients for pharmaceutical, nutraceutical (Superba®, NKO®, and K·REAL®), aquaculture (QRILL™ Aqua), and animal feed applications (QRILL™ Pet), including INVI™, a highly concentrated protein isolate, and LYSOVETA™, a targeted transporter of EPA and DHA from krill. Aker BioMarine's fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world. The company's strong focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste
